Amarin Corp Plcuk (AMRN) Tax Rate Growth (3y) (2013 - 2026)

Amarin Corp Plcuk (AMRN) Tax Rate Growth (3y) (2013 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Gsk 93,699,046.73 Bn 93,699,041.77 Bn 7.76 Bn
2 Eli Lilly 1,012.06 Bn 1,006.77 Bn 16.22 Bn
3 Johnson & Johnson 560.67 Bn 538.62 Bn 15.96 Bn
4 AbbVie 402.20 Bn 392.85 Bn 10.78 Bn
5 Merck 298.59 Bn 292.94 Bn 12.09 Bn
6 Amgen 188.77 Bn 176.74 Bn 5.87 Bn
7 Gilead Sciences 160.22 Bn 152.49 Bn 5.52 Bn
8 Pfizer 148.19 Bn 135.42 Bn -1.21 Bn
9 Bristol Myers Squibb 116.72 Bn 106.26 Bn 8.07 Bn
10 Amarin Corp Plcuk 5.84 Bn 5.66 Bn 17.77 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -696.00
Dec 31, 2025 -3,621.00
Sep 30, 2025 3,702.00
Jun 30, 2025 284.00
Mar 31, 2025 -383.00
Dec 31, 2024 -1,620.00
Sep 30, 2024 -1,533.00
Jun 30, 2024 3,543.00
Mar 31, 2024 4,728.00
Dec 31, 2023 -14,278.00
Sep 30, 2023 410.00
Mar 31, 2023 -2,384.00
Dec 31, 2016 1,845.00
Sep 30, 2016 281.00
Jun 30, 2016 731.00
Mar 31, 2016 -402.00
Dec 31, 2015 4,216.00
Sep 30, 2015 1,734.00
Jun 30, 2015 737.00
Mar 31, 2015 83.00